These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25200111)

  • 1. Drooling in Parkinson's disease: a review.
    Srivanitchapoom P; Pandey S; Hallett M
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1109-18. PubMed ID: 25200111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialorrhea in Parkinson's Disease.
    Isaacson J; Patel S; Torres-Yaghi Y; Pagán F
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33142833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drooling in Parkinson's Disease: Evidence of a Role for Divided Attention.
    Reynolds H; Miller N; Walker R
    Dysphagia; 2018 Dec; 33(6):809-817. PubMed ID: 29785679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.
    Jost WH
    J Neural Transm (Vienna); 2016 Jan; 123(1):51-5. PubMed ID: 26138438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of progression of Parkinson's disease on drooling in various ethnic groups.
    Rana AQ; Yousuf MS; Awan N; Fattah A
    Eur Neurol; 2012; 67(5):312-4. PubMed ID: 22517489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson's disease: a systematic review and network meta-analysis.
    Santos Junior LC; Santos JR; Reis A; Faria-E-Silva AL; Leal PC
    Clin Oral Investig; 2023 Jun; 27(6):2449-2463. PubMed ID: 37036514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drooling rating scales in Parkinson's disease: A systematic review.
    Nascimento D; Carmona J; Mestre T; Ferreira JJ; Guimarães I
    Parkinsonism Relat Disord; 2021 Oct; 91():173-180. PubMed ID: 34583888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drooling in Parkinson's disease: a novel speech and language therapy intervention.
    Marks L; Turner K; O'Sullivan J; Deighton B; Lees A
    Int J Lang Commun Disord; 2001; 36 Suppl():282-7. PubMed ID: 11340797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia.
    Karakoc M; Yon MI; Cakmakli GY; Ulusoy EK; Gulunay A; Oztekin N; Ak F
    Neurol Sci; 2016 Dec; 37(12):1987-1991. PubMed ID: 27613712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
    Ondo WG; Hunter C; Moore W
    Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
    J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease.
    Farber NM; Perez-Lloret S; Gamzu ER
    Curr Top Med Chem; 2015; 15(10):939-54. PubMed ID: 25832720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
    Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
    Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
    Egevad G; Petkova VY; Vilholm OJ
    J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features associated with drooling in Parkinson's disease.
    Nascimento D
    Neurol Sci; 2021 Mar; 42(3):895-903. PubMed ID: 33443673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expiratory Muscle Strength Training for Drooling in Adults with Parkinson's Disease.
    Cocks N; Rafols J; Embley E; Hill K
    Dysphagia; 2022 Dec; 37(6):1525-1531. PubMed ID: 35171321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor subtypes and other risk factors associated with drooling in Parkinson's disease patients.
    Mao CJ; Xiong YT; Wang F; Yang YP; Yuan W; Zhu C; Chen J; Liu CF
    Acta Neurol Scand; 2018 May; 137(5):509-514. PubMed ID: 29315470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.